Literature DB >> 14226129

DIHYDROXYBUSULFAN (NSC-39069) IN CHRONIC MYELOCYTIC LEUKEMIA AND MISCELLANEOUS MALIGNANT NEOPLASMS.

V LOEB.   

Abstract

Entities:  

Keywords:  BUSULFAN; DRUG THERAPY; GERIATRICS; LEUKEMIA, MYELOCYTIC; NEOPLASM THERAPY; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14226129

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  1 in total

1.  Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning.

Authors:  J Topaly; S Fruehauf; A D Ho; W J Zeller
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.